[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate

C34H54N2O2 — CID 151713075

IUPAC[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate
SMILESCC(C)CCC[C@@H](C)[C@H]1C(OC(=O)c2cc(N)cc(N)c2)C[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C34H54N2O2/c1-21(2)9-8-10-22(3)31-30(38-32(37)23-17-25(35)19-26(36)18-23)20-29-27-13-12-24-11-6-7-15-33(24,4)28(27)14-16-34(29,31)5/h17-19,21-22,24,27-31H,6-16,20,35-36H2,1-5H3/t22-,24?,27-,28+,29+,30?,31+,33+,34+/m1/s1
InChIKeyRGYRPBBHPCFIDY-TWLBPOEASA-N
MW522.82 g/mol
LogP8.50
Rot. Bonds7

About [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate

[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate (PubChem CID 151713075) has the molecular formula C34H54N2O2 and a molecular weight of 522.82 g/mol. Its IUPAC name is [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate.

Molecular Properties

Compound Name[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate
PubChem CID151713075
Molecular FormulaC34H54N2O2
Molecular Weight522.82 g/mol
Exact Mass522.42
IUPAC Name[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate
SMILESCC(C)CCC[C@@H](C)[C@H]1C(OC(=O)c2cc(N)cc(N)c2)C[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C34H54N2O2/c1-21(2)9-8-10-22(3)31-30(38-32(37)23-17-25(35)19-26(36)18-23)20-29-27-13-12-24-11-6-7-15-33(24,4)28(27)14-16-34(29,31)5/h17-19,21-22,24,27-31H,6-16,20,35-36H2,1-5H3/t22-,24?,27-,28+,29+,30?,31+,33+,34+/m1/s1
InChIKeyRGYRPBBHPCFIDY-TWLBPOEASA-N
XLogP8.50
TPSA78.34 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500522.82
LogP ≤ 58.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate?
The IUPAC name of [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate (CID 151713075) is [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate.
What is the SMILES notation for [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate?
The canonical SMILES for [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate is CC(C)CCC[C@@H](C)[C@H]1C(OC(=O)c2cc(N)cc(N)c2)C[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate?
The InChIKey is RGYRPBBHPCFIDY-TWLBPOEASA-N. The full InChI is InChI=1S/C34H54N2O2/c1-21(2)9-8-10-22(3)31-30(38-32(37)23-17-25(35)19-26(36)18-23)20-29-27-13-12-24-11-6-7-15-33(24,4)28(27)14-16-34(29,31)5/h17-19,21-22,24,27-31H,6-16,20,35-36H2,1-5H3/t22-,24?,27-,28+,29+,30?,31+,33+,34+/m1/s1.
What are the key properties of [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate?
[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate has a molecular weight of 522.82 g/mol, XLogP of 8.50, 7 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-yl] 3,5-diaminobenzoate is sourced from PubChem (CID 151713075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).